TCEAL7, a putative tumor suppressor gene, negatively regulates NF-kappaB pathway

Area of Science:

• Molecular Biology
• Cancer Biology
• Cell Signaling

Background:

• Transcription elongation factor A-like 7 (TCEAL7) is a frequently downregulated gene in ovarian cancer.
• Previous studies indicated TCEAL7 promotes anchorage-independent growth and modulates Myc activity.

Purpose of the Study:

• To investigate the role of TCEAL7 in regulating nuclear factor-kappaB (NF-κB) signaling pathway.
• To elucidate the mechanism by which TCEAL7 influences NF-κB activity in ovarian cancer cells.

Main Methods:

• Short hairpin RNA (shRNA)-mediated knockdown of TCEAL7 in immortalized ovarian surface epithelial (OSE) cells.
• Reporter assays, gel-shift assays, and transient transfection to assess NF-κB activity.
• Analysis of NF-κB target gene expression, including pro-proliferative, pro-angiogenic, inflammatory, and anti-apoptotic genes.
• Inhibition of NF-κB pathway using IκB kinase (IKK) inhibitor (BMS 345541).
• Chromatin immunoprecipitation (ChIP) assays to evaluate protein recruitment to gene promoters.

Main Results:

• TCEAL7 downregulation led to increased NF-κB binding and activity in OSE cells and ovarian cancer cell lines.
• Overexpression of TCEAL7 inhibited NF-κB activation in TCEAL7-downregulated cells.
• TCEAL7-knockdown cells exhibited elevated expression of NF-κB target genes involved in proliferation, angiogenesis, inflammation, and apoptosis.
• Inhibition of NF-κB attenuated the survival and proliferation of TCEAL7-knockdown cells.
• ChIP assays showed increased recruitment of p65 and p300 to IL-8 and IL-6 promoters in TCEAL7-downregulated cells.

Conclusions:

• TCEAL7 negatively regulates the NF-κB signaling pathway at the transcriptional level.
• TCEAL7 modulates the transcriptional activity of NF-κB on its target gene promoters.
• Dysregulation of TCEAL7 may contribute to elevated NF-κB activity in ovarian cancer, providing a novel mechanism for cancer progression.